Literature DB >> 8466855

Predominant expression of nPKC eta, a Ca(2+)-independent isoform of protein kinase C in epithelial tissues, in association with epithelial differentiation.

S Osada1, Y Hashimoto, S Nomura, Y Kohno, K Chida, O Tajima, K Kubo, K Akimoto, H Koizumi, Y Kitamura.   

Abstract

Of the nine known members of the protein kinase C (PKC) family, we found that novel (n-) PKC eta, a newly isolated Ca(2+)-independent isoform, was expressed at the highest level in the epidermis of mouse skin and epithelia of the digestive and respiratory tracts including the tongue, esophagus, forestomach, glandular stomach, intestine, colon, trachea, and bronchus. Expression of nPKC eta mRNA in these epithelial tissues was 3-10 times that in the brain and was especially high in squamous epithelium. Two other PKC isoforms, conventional (c-) PKC alpha and nPKC delta, were also expressed in these epithelial tissues, but no cPKC gamma was detected. In situ hybridization and immunohistochemical analyses demonstrated the localization of nPKC eta in suprabasal layers of the skin, tongue, esophagus, and forestomach. In the intestine, it was expressed in the epithelial cells of villi, but not of crypts. In the lung, only bronchial epithelium expressed nPKC eta. The localization of nPKC eta in differentiating or differentiated epithelial cells, rather than in proliferating basal cells, suggests the involvement of nPKC eta in epithelial differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8466855

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  20 in total

1.  Translational control of protein kinase Ceta by two upstream open reading frames.

Authors:  Hadas Raveh-Amit; Adva Maissel; Jonathan Poller; Liraz Marom; Orna Elroy-Stein; Michal Shapira; Etta Livneh
Journal:  Mol Cell Biol       Date:  2009-09-21       Impact factor: 4.272

Review 2.  Transcription factor regulation of epidermal keratinocyte gene expression.

Authors:  R L Eckert; J F Welter
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

3.  Role of AMP-18 in oral mucositis.

Authors:  Peili Chen; Mark Lingen; Stephen T Sonis; Margaret M Walsh-Reitz; F Gary Toback
Journal:  Oral Oncol       Date:  2011-07-06       Impact factor: 5.337

4.  The eta isoform of protein kinase C is localized on rough endoplasmic reticulum.

Authors:  K Chida; H Sagara; Y Suzuki; A Murakami; S Osada; S Ohno; K Hirosawa; T Kuroki
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

5.  Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C.

Authors:  M Ohba; K Ishino; M Kashiwagi; S Kawabe; K Chida; N H Huh; T Kuroki
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

6.  MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.

Authors:  D K Ways; C A Kukoly; J deVente; J L Hooker; W O Bryant; K J Posekany; D J Fletcher; P P Cook; P J Parker
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Partial purification of a type eta protein kinase C from murine brain: separation from other protein kinase C isoenzymes and characterization.

Authors:  R Zang; H J Müller; K Kielbassa; F Marks; M Gschwendt
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

Review 8.  Regulation of protein kinase C and role in cancer biology.

Authors:  G C Blobe; L M Obeid; Y A Hannun
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

9.  Relationship between serum calcium and CA 19-9 levels in colorectal cancer.

Authors:  Peter Fuszek; Peter Lakatos; Adam Tabak; Janos Papp; Zsolt Nagy; Istvan Takacs; Henrik Csaba Horvath; Peter Laszlo Lakatos; Gabor Speer
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

10.  Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.

Authors:  Anna C Pavlick; Jennifer Wu; John Roberts; Mark A Rosenthal; Anne Hamilton; Scott Wadler; Kathleen Farrell; Michelle Carr; David Fry; Anthony J Murgo; Ruth Oratz; Howard Hochster; Leonard Liebes; Franco Muggia
Journal:  Cancer Chemother Pharmacol       Date:  2009-02-17       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.